Grommet Insertion or Removal — Cost, Top Hospitals & Success Rates | MyMedicPlus

Grommet insertion (myringotomy with tympanostomy tube placement) is one of the most commonly performed surgical procedures in children worldwide. A grommet is a tiny hollow bobbin-shaped tube inserted through a small incision in the eardrum (tympanic membrane) to ventilate the middle ear, equalise pressure, and allow drainage of trapped fluid. By restoring normal middle ear aeration, grommets immediately improve hearing in the majority of children with chronic otitis media with effusion (glue ear) or recurrent acute otitis media, facilitating language development, school performance, and quality of life.

Glue ear — in which thick, viscous fluid accumulates in the middle ear behind an intact eardrum — affects approximately 80% of children under the age of 10 years at some point, and around 5–10% have persistent bilateral glue ear causing significant conductive hearing loss. In the UK, grommet insertion is the most frequently performed surgical procedure under general anaesthesia in children; in the United States, over 650,000 tympanostomy tube procedures are performed annually. The procedure is also performed in adults with Eustachian tube dysfunction, chronic middle ear effusion, or barotrauma.

Grommet removal, performed when grommets fail to extrude naturally, block, or cause chronic otorrhoea (ear discharge), is a straightforward outpatient procedure. Both insertion and removal are routinely offered through medical tourism programmes, with ENT centres in India, Thailand, and Malaysia providing experienced paediatric and adult otolaryngology services at a fraction of Western private healthcare costs.

Grommet insertion addresses middle ear ventilation failure in a variety of clinical scenarios:

• Chronic otitis media with effusion (glue ear) — persistent bilateral middle ear fluid for 3 months or more with associated hearing loss ≥25 dB in the better ear; the most common indication
• Recurrent acute otitis media (AOM) — 3 or more episodes in 6 months, or 4 or more episodes in 12 months, especially with documented hearing loss or speech delay
• Eustachian tube dysfunction — chronic pressure imbalance, aural fullness, and muffled hearing in adults; grommets provide temporary pressure equalisation while Eustachian tube function is addressed
• Barotrauma — middle ear injury from rapid pressure change during air travel or diving; refractory cases may benefit from short-term grommet insertion
• Cleft palate-associated glue ear — almost universal in children with cleft palate due to Eustachian tube musculature abnormalities; grommets are routinely inserted at time of palate repair
• Down syndrome-associated otitis media — higher prevalence and severity; often requires multiple grommet insertions over childhood
• Cholesteatoma prevention — attic retraction pockets threatening to develop into cholesteatoma may be managed with ventilation tube support
• Pre-cochlear implant — some centres insert grommets at time of cochlear implantation in children with a history of chronic otitis media

Candidates for grommet insertion include children with bilateral otitis media with effusion causing hearing loss ≥25 dB HL persisting for 3 months or longer, children with recurrent acute otitis media (3 episodes in 6 months or 4 in 12 months) with documented middle ear pathology, and adults with refractory Eustachian tube dysfunction or chronic middle ear effusion. UK NICE guidelines (NG91, 2023) recommend offering grommets to children with bilateral glue ear and documented hearing impairment that is affecting development, behaviour, or quality of life after at least 3 months watchful waiting. AAO-HNS guidelines (2023) recommend grommets for at-risk children with bilateral effusion-associated hearing loss regardless of duration.

Relative contraindications and factors requiring assessment:

• Acute upper respiratory tract infection at time of surgery — may increase risk of post-operative otorrhoea; surgery typically postponed by 2–4 weeks unless infection is resolved
• Blood clotting disorders or anticoagulant therapy — bleeding risk is minimal with this procedure but should be assessed
• Severe cardiac or pulmonary comorbidity — general anaesthesia carries higher risk; local anaesthesia with sedation may be considered in adults
• Severely atrophic or scarred tympanic membrane — may complicate tube placement; specialist assessment required
• Perforation of the tympanic membrane — active perforation precludes grommet insertion; surgical closure (myringoplasty) may be needed first
• Children with mild unilateral effusion and normal hearing — watchful waiting is appropriate; NICE guidelines recommend against routine insertion in unilateral cases without additional risk factors

The choice of grommet type and surgical technique is tailored to the patient's age, clinical history, and expected duration of middle ear ventilation required:

Grommet types:

• Short-term grommets (Shah, Donaldson, Armstrong) — Small flanged tubes with inner flange diameters of 1.0–1.4 mm; designed to remain in place for 6–18 months before spontaneous extrusion; used for first-episode or standard-risk glue ear
• Long-term grommets (T-tubes, Goode T-tubes, Per-Lee tubes) — T-shaped or flanged devices designed to remain in place for 2–4 years or more; used in high-risk patients (Down syndrome, cleft palate, recurrent failure of short-term grommets, severe Eustachian tube dysfunction); require surgical removal as they rarely extrude spontaneously
• Silicone vs. fluoroplastic (PTFE) tubes — Silicone tubes are softer and may be associated with earlier extrusion; PTFE tubes are more rigid and may retain longer

Insertion technique: Under general anaesthesia (standard for children) or local anaesthesia with topical anaesthetic (EMLA cream or phenol) in cooperative adults, an operating microscope provides magnified visualisation. A small radial or circumferential myringotomy incision is made in the anteroinferior quadrant of the pars tensa of the tympanic membrane. Any effusion is aspirated using a fine suction cannula. The grommet is introduced through the incision with forceps and positioned with the inner flange inside the middle ear and the outer flange in contact with the external tympanic membrane surface. No sutures are required. Total procedure time is 10–20 minutes per ear.

Grommet removal technique: When grommets fail to extrude naturally, removal is performed under general anaesthesia (children) or with topical anaesthesia (adults). The tube is grasped with fine crocodile forceps and removed from the myringotomy site; any granulation tissue around the tube is removed. Small tympanic membrane perforations from the tube site usually close spontaneously within 4 weeks; larger perforations may require myringoplasty.

Grommet insertion produces rapid, measurable improvements in hearing and middle ear function with well-documented outcomes:

• Hearing improvement: Immediate improvement in conductive hearing loss in >90% of patients; average improvement of 12–18 dB HL in children with glue ear within 1–2 weeks of insertion
• Acute otitis media recurrence: Grommets reduce AOM recurrence rates by approximately 56% in children (Cochrane Review, 2021); some episodes of AOM manifest as otorrhoea (discharge through the tube) rather than pain, which is generally less distressing than AOM with intact eardrum
• Language and development: Earlier systematic reviews suggested benefit for speech and language development; more recent meta-analyses (MRC TARGET trial, BMJ 2001) show modest long-term developmental differences, but short-term hearing normalisation is consistently beneficial
• Quality of life: Systematic reviews confirm significant improvement in health-related quality of life scores, sleep quality, and behavioural outcomes in children with chronic glue ear managed with grommets
• Cleft palate patients: Grommet insertion at palate repair effectively prevents development of conductive hearing loss in this high-risk group throughout childhood
• Adults with Eustachian tube dysfunction: Symptom resolution in 70–80% of carefully selected adults; less effective in those with ongoing Eustachian tube pathology

Grommet insertion is one of the safest surgical procedures performed under general anaesthesia. Complication rates are low, and most complications are minor and self-resolving:

Procedure-related complications:

• Post-operative otorrhoea (ear discharge) — Most common complication; occurs in 15–25% of patients; typically resolves with topical antibiotic-steroid drops (ciprofloxacin/dexamethasone); persistent otorrhoea in 5–10% may require systemic antibiotics or grommet removal
• Early grommet blockage — dried secretions or cerumen may occlude the tube lumen; usually resolves with topical drops or microsuction
• Premature extrusion — Grommet falls out before adequate ventilation has been achieved (within 3 months); may require re-insertion
• Medial displacement — Tube displaced into middle ear space; rare; requires surgical retrieval
• Tympanic membrane perforation (persistent) — Occurs in 2–3% of cases after grommet extrusion; most close spontaneously within 4–6 weeks; 1–2% require myringoplasty

Long-term sequelae (increased with multiple grommet sets or long-term tubes):

• Tympanosclerosis — White chalky calcification visible on the tympanic membrane; affects 30–50% of ears after grommet insertion; almost never causes clinically significant hearing loss
• Eardrum retraction or atelectasis — Chronic negative middle ear pressure from recurrent disease can cause eardrum to retract inward; grommets may prevent this in susceptible ears
• Anaesthetic risks — General anaesthetic in healthy children carries very low risk; anaesthetic mortality in elective paediatric procedures is approximately 1:40,000–100,000

Grommet insertion and removal are day surgery procedures; most children and adults are discharged within 2–4 hours of the procedure:

• Immediate recovery: Recovery from general anaesthesia takes 30–60 minutes; children may be sleepy or irritable; mild discomfort in the ears is common for a few hours; paracetamol (acetaminophen) is sufficient for pain relief
• Day 1–3: A small amount of blood-stained or clear discharge from the ear is normal; antibiotic-steroid ear drops (ciprofloxacin/dexamethasone) are prescribed for 5–7 days to reduce early otorrhoea risk
• Week 1–2: Most patients return to normal activities including school or work within 1–2 days; hearing improvement is typically noticed immediately; first post-operative review at 4–6 weeks
• Ongoing monitoring: Pure tone audiometry 4–8 weeks after insertion to document hearing improvement; annual or semi-annual otoscopy to check grommet position and tympanic membrane health; grommets usually extrude spontaneously within 6–12 months (short-term types)
• Water precautions: Guidance varies; most contemporary evidence (AAO-HNS 2023 guidelines) suggests routine water precautions (ear plugs, avoiding submersion) are not necessary for grommets in children; surface swimming and bath water generally do not cause problems; diving and jumping into water should be avoided; plug use may be appropriate for patients with recurrent water-related otorrhoea
• Grommet removal follow-up: Tympanic membrane inspection at 4–6 weeks post-removal to confirm spontaneous perforation closure

Grommet insertion is a cost-effective procedure; however, private costs in Western countries can be significant due to operating theatre, anaesthesia, and surgeon fees:

• United States: $2,000–$6,000 per procedure (bilateral); higher with adenoidectomy performed simultaneously
• United Kingdom (private): £1,500–£3,500; NHS waiting times for grommet insertion have exceeded 12 months in some regions following post-pandemic backlogs
• India: $200–$600 (bilateral grommet insertion; general anaesthesia included at accredited ENT centres)
• Thailand: $400–$1,000 at JCI-accredited hospitals
• Malaysia: $300–$800
• Turkey: $300–$900

Cost drivers include: anaesthesia type (general vs. local), whether adenoidectomy is performed simultaneously (frequently recommended by ENT surgeons for children with concurrent adenoid hypertrophy), grommet type (long-term T-tubes are more expensive than short-term grommets), and number of ears treated (unilateral vs. bilateral). Grommet removal costs are similar or slightly lower than insertion. Medical tourism families travelling for grommet insertion should factor in costs for accompanying parent accommodation and return flights; the procedure itself is typically performed within 1–2 days of arrival, with discharge the same day.

Before proceeding to grommet insertion, several non-surgical approaches and observation strategies are recommended by major guidelines:

• Watchful waiting (active monitoring) — Recommended as the first-line approach for most children with glue ear by NICE (NG91) and AAO-HNS guidelines; the majority of cases of otitis media with effusion resolve spontaneously within 3 months; monitoring with repeat audiometry and otoscopy at 3-month intervals is appropriate for non-at-risk children
• Autoinflation (Otovent device) — A nasal balloon device that the child blows up through one nostril to open the Eustachian tube and equalise middle ear pressure; a Cochrane review (2013) and the ATTRACT trial (JAMA, 2015) showed modest benefit for short-term resolution of glue ear; recommended by NICE NG91 as an adjunct to watchful waiting in children aged 4 and over
• Hearing aids — An alternative to grommets for children with bilateral hearing loss from glue ear who are not surgical candidates or whose parents prefer non-surgical management; bone-anchored hearing aids (BAHA) can be used in children with severe Eustachian tube dysfunction
• Nasal steroids — Intranasal corticosteroid sprays reduce adenoid lymphoid tissue and nasal inflammation; modest evidence for glue ear resolution; recommended as an adjunct but not as primary treatment
• Adenoidectomy alone — Removal of the adenoid pad (without grommets) reduces AOM recurrence and may improve middle ear ventilation through Eustachian tube unblocking; most effective when adenoid hypertrophy is clinically significant
• Antibiotics — Not recommended for chronic otitis media with effusion (glue ear); appropriate for acute bacterial otitis media episodes; do not prevent recurrence
• Eustachian tube balloon dilation — A minimally invasive endoscopic procedure available for adults and older children with refractory Eustachian tube dysfunction; limited but growing evidence base; reduces need for long-term grommet insertion in selected adults